Federal Court allows Janssen to amend statement of defence in litigation with Apotex
The Federal Court has allowed Janssen Inc. leave to amend its statement of defence in ongoing litigation with Apotex Inc., but has dismissed the innovator drugmaker’s motion to have evidence heard...To view the full article, register now.
Already a subscriber? Click here to view full article